Chronos Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
26 Beaumont St, Oxford, Oxfordshire, OX1...Phone Number
+44 1865000000Website
www.chronostherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Chronos Therapeutics
Chronos Therapeutics Ltd is a privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders. Chronos has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, ChronoscreenTM. It has an extensive library of re-purposed molecules showing promise for brain and neurological diseases. The lead compound, RDC5, is being developed for the fatal neurodegenerative disease, Amyotrophic Lateral Sclerosis (ALS). Chronos recently acquired three new chemical entity (NCE) development programs for CNS diseases. The most advanced programme is initially targeting fatigue associated with multiple sclerosis with the others addressing behavioral and neurodegenerative conditions. Chronos' shareholders include the University of Oxford, Vulpes Testudo and Life Sciences funds, Odey European and Swan funds, an affiliate of Shire PLC, the Board and Management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chronos Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Chronos Therapeutics recently announced quarterly report
Check out if Chronos Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Chronos Therapeutics launches new products
Funding: Get notified immidiatlly once Chronos Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Chronos Therapeutics
Click to see if Chronos Therapeutics had a recent Job posting/layoffs
Chronos Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Chronos Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Chronos Therapeutics
Find 3 more new buyers
Compare Similar Companies to Chronos Therapeutics
Compare insights from companies similar to Chronos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Chronos Therapeutics
<$5M
11-50
Private
$80.2M
2009
N/A
Company Profile Activity
Activity Insights
Chronos Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Chronos Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Chronos Therapeutics.
Chronos Therapeutics financials insights
Gather financial insights about Chronos Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$500K
Series A
$32M
2015
Private Equity
$100K
2016
Series B
$47.6M
Chronos Therapeutics Tech Stack
A closer look at the technologies used by Chronos Therapeutics
Chronos Therapeutics News & Media
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chronos Therapeutics
Sign Up For FreeTo access detailed company insights
Chronos Therapeutics Ltd is a privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders. Chronos has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, ChronoscreenTM. It has an extensive library of re-purposed molecules showing promise... Read More
